The British pharmaceutical company GlaxoSmithKline (GSK) announced that the antibody cocktail it has prepared as an anti-coronavirus treatment in partnership with the American Vir Biotechnology is effective against the Omicron variant.
Specifically, the company announced that Sotrovimab is effective against all 37 Omicron mutations that scientists have identified.
The company cites data from an initial stage study, which has not yet been published.
The drug, which will be released under the name Xevudy, was approved for use last week by the British Regulatory Authority for Medicines and Health Products.
It has been shown to reduce the risk of hospitalization and death by 79%.
In the context of the investigation of a case related to the burglary of an EAC substation in the province of Famagusta and...
The candidates of the municipal elections are expected to be thrown into the battle on the 9th of next June...
While we've all heard that we should take 10.000 steps a day, that number can…
As every year, this year the municipality of Paralimni organizes a rich program for...
As every year, this year the Municipality of Ayia Napa organizes a rich music and dance program...
The night of Holy Saturday in Limassol was eventful. Specifically, in one case in Ypsonas...